CCL2 and infectious otitis media: This study was the first to report that supplementing fractalkine during hepatic encephalopathy suppresses CCL2 concentrations in the cortex, which indicates that the increase of CCL2 observed during AOM-induced hepatic encephalopathy is dependent upon the suppression of fractalkine.